tiprankstipranks
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
US Market

Cognition Therapeutics (CGTX) Financial Statements

Compare
283 Followers

Cognition Therapeutics Financial Overview

Cognition Therapeutics's market cap is currently $25.33M. The company's EPS TTM is $-0.957; its P/E ratio is ―; Cognition Therapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -252.00K$ -235.00K$ -93.00K$ -98.00K$ -81.00K
Operating Income$ -50.72M$ -43.55M$ -28.60M$ -17.41M$ -17.83M
EBITDA$ -25.51M$ -21.13M$ -13.38M$ -5.99M$ -3.50M
Net Income$ -25.79M$ 757.00K$ -10.29M$ -10.07M$ -6.95M
Balance Sheet
Cash & Short-Term Investments$ 29.92M$ 41.56M$ 54.72M$ 5.19M$ 2.89M
Total Assets$ 35.16M$ 50.42M$ 59.14M$ 7.12M$ 7.46M
Total Debt$ 1.24M$ 1.48M$ 0.00$ 12.85M$ 6.90M
Net Debt$ -28.68M$ -40.08M$ -54.72M$ 7.66M$ 4.01M
Total Liabilities$ 10.69M$ 10.18M$ 7.86M$ 75.30M$ 65.88M
Stockholders' Equity$ 24.47M$ 40.25M$ 51.27M$ -68.18M$ -58.42M
Cash Flow
Free Cash Flow$ -16.16M$ -18.70M$ -3.66M$ -3.44M$ -3.24M
Operating Cash Flow$ -16.02M$ -18.53M$ -3.63M$ -3.43M$ -3.10M
Investing Cash Flow$ -147.00K$ -171.00K$ -27.00K$ -10.00K$ -144.00K
Financing Cash Flow$ 4.52M$ 5.55M$ 53.20M$ 5.76M$ 2.79M
Currency in USD

Cognition Therapeutics Earnings and Revenue History

Cognition Therapeutics Debt to Assets

Cognition Therapeutics Cash Flow

Cognition Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis